Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical study

BackgroundBreast cancer ranks first in women, and is the second cause of death in this gender. In addition to genetics, the environment contributes to the development of the disease, although the factors involved are not well known. Among the latter is the influence of microorganisms and, therefore, attention is recently being paid to the mammary microbiota. We hypothesize that the risk of breast cancer could be associated with the composition and functionality of the mammary/gut microbiota, and that exposure to environmental contaminants (endocrine disruptors, EDCs) might contribute to alter these microbiota.MethodsWe describe a case-control clinical study that will be performed in women between 25 and 70 years of age. Cases will be women diagnosed and surgically intervened of breast cancer (stages I and II). Women with antecedents of cancer or advanced tumor stage (metastasis), or who have received antibiotic treatment within a period of 3 months prior to recruitment, or any neoadjuvant therapy, will be excluded. Controls will be women surgically intervened of breast augmentation or reduction. Women with oncological, gynecological or endocrine history, and those who have received antibiotic treatment within a period of 3 months prior to recruitment will also be excluded. Blood, urine, breast tissue and stool samples will be collected. Data regarding anthropometric, sociodemographic, reproductive history, tumor features and dietary habits will be gathered.Metabolomic studies will be carried out in stool and breast tissue samples. Metagenomic studies will also be performed in stool and breast tissue samples to ascertain the viral, fungal, bacterial and archaea populations of the microbiota. Quantitation of estrogens, estrogen metabolites and EDCs in samples of serum, urine and breast tissue will also be performed.DiscussionThis is the first time that the contribution of bacteria, archaea, viruses and fungi together with their alteration by environmental contaminants to the risk of breast cancer will be evaluated in the same study. Results obtained could contribute to elucidate risk factors, improve the prognosis, as well as to propose novel intervention studies in this disease.Trial registrationClinicalTrials.gov NCT03885648, 03/25/2019. Retrospectively registered.

[1]  K. Lai,et al.  Bisphenol A alters gut microbiome: Comparative metagenomics analysis. , 2016, Environmental pollution.

[2]  X. Hua,et al.  Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota , 2018, British Journal of Cancer.

[3]  Alexander F. Auch,et al.  MEGAN analysis of metagenomic data. , 2007, Genome research.

[4]  G. Coppola,et al.  Microbiota effects on cancer: from risks to therapies , 2018, Oncotarget.

[5]  Jordi Segura,et al.  Quantifying endogenous androgens, estrogens, pregnenolone and progesterone metabolites in human urine by gas chromatography tandem mass spectrometry. , 2017, Talanta.

[6]  Juan M. Astorga,et al.  Breast Cancer and Its Relationship with the Microbiota , 2018, International journal of environmental research and public health.

[7]  Gerhard G. Thallinger,et al.  Wx Scout Fashion Sneaker Splash Navy Women's Keds qAS4tR1wn4 for bawln.com , 2009 .

[8]  Robert A. Edwards,et al.  Quality control and preprocessing of metagenomic datasets , 2011, Bioinform..

[9]  Jean M. Macklaim,et al.  Microbiota of Human Breast Tissue , 2014, Applied and Environmental Microbiology.

[10]  Yuanyuan Li.  Epigenetic Mechanisms Link Maternal Diets and Gut Microbiome to Obesity in the Offspring , 2018, Front. Genet..

[11]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[12]  A. Zafra-Gómez,et al.  UHPLC–MS/MS method for the determination of bisphenol A and its chlorinated derivatives, bisphenol S, parabens, and benzophenones in human urine samples , 2014, Analytical and Bioanalytical Chemistry.

[13]  J. Kleeff,et al.  Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells , 2017, Cancers.

[14]  Corey D. DeHaven,et al.  High Resolution Mass Spectrometry Improves Data Quantity and Quality as Compared to Unit Mass Resolution Mass Spectrometry in High- Throughput Profiling Metabolomics , 2014 .

[15]  S. Givan,et al.  Effects of exposure to bisphenol A and ethinyl estradiol on the gut microbiota of parents and their offspring in a rodent model , 2016, Gut microbes.

[16]  Samuel P. Caudill,et al.  Urinary Creatinine Concentrations in the U.S. Population: Implications for Urinary Biologic Monitoring Measurements , 2004, Environmental health perspectives.

[17]  G. Reid.  Can breast microbiota provide protective effects against cancer? , 2016, Future Microbiology.

[18]  Wenke Wang,et al.  Adsorption Property and Mechanism of Oxytetracycline onto Willow Residues , 2017, International journal of environmental research and public health.

[19]  B. Wang,et al.  The effect of fucoidan on intestinal flora and intestinal barrier function in rats with breast cancer. , 2018, Food & function.

[20]  Janet M. Gray,et al.  State of the evidence 2017: an update on the connection between breast cancer and the environment , 2017, Environmental Health.

[21]  C. Hudis,et al.  Obesity and Cancer—Opportunities to Break the Link , 2016, Current Breast Cancer Reports.

[22]  Martin Hartmann,et al.  Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.

[23]  Q. Zhao,et al.  Influence of Bisphenol A on Thyroid Volume and Structure Independent of Iodine in School Children , 2015, PloS one.

[24]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[25]  L. Trasande,et al.  Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. , 2012, JAMA.

[26]  Johan Bengtsson-Palme,et al.  metaxa2: improved identification and taxonomic classification of small and large subunit rRNA in metagenomic data , 2015, Molecular ecology resources.

[27]  J. Shamonki,et al.  Microbial Dysbiosis Is Associated with Human Breast Cancer , 2014, PloS one.

[28]  S. Love,et al.  Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors , 2016, Scientific Reports.

[29]  C. Randazzo,et al.  B-glucans from Grifola frondosa and Ganoderma lucidum in breast cancer: an example of complementary and integrative medicine , 2018, Oncotarget.

[30]  L. Zitvogel,et al.  The intimate relationship between gut microbiota and cancer immunotherapy , 2018, Gut microbes.

[31]  Anne M. Evans,et al.  Organization of GC/MS and LC/MS metabolomics data into chemical libraries , 2010, J. Cheminformatics.

[32]  G. Gloor,et al.  The Microbiota of Breast Tissue and Its Association with Breast Cancer , 2016, Applied and Environmental Microbiology.

[33]  C. Skibola,et al.  Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases , 2015, Clinical Epigenetics.

[34]  Junjie Yang,et al.  Study of Microbiomes in Aseptically Collected Samples of Human Breast Tissue Using Needle Biopsy and the Potential Role of in situ Tissue Microbiomes for Promoting Malignancy , 2018, Front. Oncol..

[35]  E. Wine,et al.  The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It , 2018, Cancers.

[36]  J. Goedert,et al.  Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. , 2014, The Journal of clinical endocrinology and metabolism.

[37]  N. Olea,et al.  Urinary levels of bisphenol A, benzophenones and parabens in Tunisian women: A pilot study. , 2016, The Science of the total environment.

[38]  S. Safe,et al.  Endocrine disruption: Relevance of experimental studies in female animals to human studies , 2017 .

[39]  A. York.  Microbiome: Gut microbiota sways response to cancer immunotherapy , 2018, Nature Reviews Microbiology.

[40]  Ying Huang,et al.  E3-ligase Skp2 predicts poor prognosis and maintains cancer stem cell pool in nasopharyngeal carcinoma , 2014, Oncotarget.

[41]  J. Taubenberger,et al.  Epstein-Barr virus detection in ductal carcinoma of the breast. , 2001, Journal of the National Cancer Institute.

[42]  Saraí Aguilar-Barojas.  Fórmulas para el cálculo de la muestra en investigaciones de salud , 2005 .

[43]  Y. Ye,et al.  Human papilloma virus is associated with breast cancer , 2009, British Journal of Cancer.

[44]  Corey D. DeHaven,et al.  Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.

[45]  I. Gheorghe,et al.  Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer , 2018, Front. Immunol..

[46]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..